Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for Benzodiazepine Dependence
NCT05935553Phase 3Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2026
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baclofen in benzodiazepine dependence, sponsored by Hospices Civils de Lyon. Started Jan 2026; status: recruiting.
02
Drugs
baclofen
03
Conditions
benzodiazepine dependence
Beyond the preview
Go deeper on NCT05935553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05935553.